APA (7th ed.) Citation

Alsaadi, T., Almadani, A., Al-Hashel, J., Al Salti, A., Melikyan, G., & Khan, R. A. (2023). Commentary: Consensus Guidelines on the Appropriate Use of Brand-Name and Generic Anti-Seizure Medication for the Management of Epilepsy in the Gulf Region. Neurology & Therapy, 12(4), 1015. https://doi.org/10.1007/s40120-023-00491-8

Chicago Style (17th ed.) Citation

Alsaadi, Taoufik, Abubaker Almadani, Jasem Al-Hashel, Abdullah Al Salti, Gayane Melikyan, and Riaz Ahmed Khan. "Commentary: Consensus Guidelines on the Appropriate Use of Brand-Name and Generic Anti-Seizure Medication for the Management of Epilepsy in the Gulf Region." Neurology & Therapy 12, no. 4 (2023): 1015. https://doi.org/10.1007/s40120-023-00491-8.

MLA (9th ed.) Citation

Alsaadi, Taoufik, et al. "Commentary: Consensus Guidelines on the Appropriate Use of Brand-Name and Generic Anti-Seizure Medication for the Management of Epilepsy in the Gulf Region." Neurology & Therapy, vol. 12, no. 4, 2023, p. 1015, https://doi.org/10.1007/s40120-023-00491-8.